196 results  1 of 10 

1 Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer
Sang Hoon Lee, Eun Young Kim, Jung Min Han, Gyoonhee Han, Yoon Soo Chang
Cancer Res Treat.2023;55(3):851-864.   Published online 2023 March 20     DOI: http://dx.doi.org/10.4143/crt.2022.1527
      
2 Diagnostic Performance of Endosonography to Detect Mediastinal Lymph Node Metastasis in Patients with Radiological N1 Non–Small Cell Lung Cancer
Bo-Guen Kim, Jong Ho Cho, Sun Hye Shin, Kyungjong Lee, Sang-Won Um, Hojoong Kim, Jhingook Kim, Young Mog Shim, Byeong-Ho Jeong
Cancer Res Treat.2023;55(3):832-840.   Published online 2023 March 2     DOI: http://dx.doi.org/10.4143/crt.2022.1428
      
3 EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.2023;55(3):841-850.   Published online 2023 February 13     DOI: http://dx.doi.org/10.4143/crt.2022.1438
      
4 Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer
Rongxin Liao, Kehong Chen, Jinjin Li, Hengqiu He, Guangming Yi, Mingfeng Huang, Rongrong Chen, Lu Shen, Xiaoyue Zhang, Zaicheng Xu, Zhenzhou Yang, Yuan Peng
Cancer Res Treat.2023;55(3):814-831.   Published online 2023 January 12     DOI: http://dx.doi.org/10.4143/crt.2022.1315
      
5 Effect of total intravenous versus inhalation anesthesia on long-term oncological outcomes in patients undergoing curative resection for early-stage non-small cell lung cancer: a retrospective cohort study
Kwon Hui Seo, Ji Hyung Hong, Mi Hyoung Moon, Wonjung Hwang, Sea-Won Lee, Jin Young Chon, Hyejin Kwon, Sook Hee Hong, Sukil Kim
Korean J Anesthesiol.2023;76(4):336-347.   Published online 2022 December 28     DOI: http://dx.doi.org/10.4097/kja.22584
      
6 Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
Jang Ho Lee, Eun Young Kim, Cheol-Kyu Park, Shin Yup Lee, Min Ki Lee, Seong-Hoon Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee, Jun Hyeok Lim, Tae-Won Jang, Seung Hun Jang, Kye Young Lee, Seung Hyeun Lee, Sei Hoon Yang, Dong Won Park, Chan Kwon Park, Hye Seon Kang, Chang Dong Yeo, Chang-Min Choi, Jae Cheol Lee
Cancer Res Treat.2023;55(1):112-122.   Published online 2022 July 19     DOI: http://dx.doi.org/10.4143/crt.2022.381
      
7 Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
Cancer Res Treat.2022;54(2):315-329.   Published online 2022 February 18     DOI: http://dx.doi.org/10.4143/crt.2022.078
      
8 Assessment of Anti-tumor Efficacy of Osimertinib in Non–Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion
Yeon Joo Kim, Won Jun Ji, Jae-Cheol Lee, Sung-Min Chun, Chang-Min Choi
Cancer Res Treat.2022;54(4):985-995.   Published online 2022 January 17     DOI: http://dx.doi.org/10.4143/crt.2021.857
      
9 A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non–Small Cell Lung Cancer
Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
Cancer Res Treat.2022;54(4):1005-1016.   Published online 2021 December 3     DOI: http://dx.doi.org/10.4143/crt.2021.986
      
10 The Value of the Illness-Death Model for Predicting Outcomes in Patients with Non–Small Cell Lung Cancer
Kum Ju Chae, Hyemi Choi, Won Gi Jeong, Jinheum Kim
Cancer Res Treat.2022;54(4):996-1004.   Published online 2021 November 19     DOI: http://dx.doi.org/10.4143/crt.2021.902
      
11 TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
Anurag Mehta, Himanshi Diwan, Divya Bansal, Manoj Gupta
J Pathol Transl Med.2022;56(1):53-56.   Published online 2021 November 16     DOI: http://dx.doi.org/10.4132/jptm.2021.09.16
      
12 Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials
Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang
Cancer Res Treat.2022;54(3):803-816.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4143/crt.2021.764
      
13 Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
J Pathol Transl Med.2021;55(6):398-405.   Published online 2021 October 6     DOI: http://dx.doi.org/10.4132/jptm.2021.08.08
      
14 Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Cancer Res Treat.2022;54(3):767-781.   Published online 2021 September 30     DOI: http://dx.doi.org/10.4143/crt.2021.651
      
15 Predictive Value of Interstitial Lung Abnormalities for Postoperative Pulmonary Complications in Elderly Patients with Early-Stage Lung Cancer
Won Gi Jeong, Yun-Hyeon Kim, Jong Eun Lee, In-Jae Oh, Sang Yun Song, Kum Ju Chae, Hye Mi Park
Cancer Res Treat.2022;54(3):744-752.   Published online 2021 September 28     DOI: http://dx.doi.org/10.4143/crt.2021.772
      
16 miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non–Small Cell Lung Cancer Cells by Targeting USP37
Mi Seong Kim, So Hui Kim, Sei Hoon Yang, Min Seuk Kim
Cancer Res Treat.2022;54(2):445-457.   Published online 2021 August 3     DOI: http://dx.doi.org/10.4143/crt.2021.622
      
17 SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer
Anurag Mehta, Divya Bansal, Rupal Tripathi, Ankush Jajodia
J Pathol Transl Med.2021;55(5):307-316.   Published online 2021 June 21     DOI: http://dx.doi.org/10.4132/jptm.2021.05.11
      
18 Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
Chaelin Lee, Miso Kim, Dong-Wan Kim, Tae Min Kim, Soyeon Kim, Sun-Wha Im, Yoon Kyung Jeon, Bhumsuk Keam, Ja-Lok Ku, Dae Seog Heo
Cancer Res Treat.2022;54(1):140-149.   Published online 2021 May 3     DOI: http://dx.doi.org/10.4143/crt.2021.385
      
19 Surgical Impacts of Metastatic Non-small Cell Lung Cancer to the Thoracic and Lumbar Spine
Jong-myung Jung, Seung-Jae Hyun, Ki-Jeong Kim
J Korean Med Sci.2021;36(7):e52.  Published online 2021 February 1     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e52
      
20 An Unusual Case of Metastatic Non-Small Cell Lung Cancer Misidentified as Anaplastic Thyroid Cancer
Hye Mi Ko, Je-Ryong Kim
Int J Thyroidol.2020;13(2):170-174.   Published online 2020 November 30     DOI: http://dx.doi.org/10.11106/ijt.2020.13.2.170
      

 1 of 10